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Abstract 
Objective: To investigate the relationship between macular choroidal thickness 
measured by high-penetrating swept-source optical coherence tomography (SS-OCT) 
and angiographic findings in central serous chorioretinopathy (CSC). 
Design: Prospective cross-sectional case series. 
Participants and Controls: Forty-four patients with CSC (34 eyes) and 17 volunteer 
subjects (17 normal eyes). 
Methods: All subjects underwent a comprehensive ophthalmologic and SS-OCT 
prototype examination. All patients with CSC also underwent simultaneous fluorescein 
angiography (FA) and indocyanine green angiography (IA). Mean regional choroidal 
thickness measurements on the Early Treatment Diabetic Retinopathy Study (ETDRS) 
layout and squared sector grids were obtained by three-dimensional raster scanning 
using SS-OCT. 
Main Outcome Measures: Macular choroidal thickness and angiographic 
abnormalities. 
Results: Mean whole macular choroidal thickness in eyes with CSC (total, 329.3 ± 83.0 
m; classic CSC, 326.9 ± 83.1 m; chronic CSC, 325.4 ± 93.3 m; and multifocal 
posterior pigment epitheliopathy, 359.0 ± 15.5 m) was greater than that in normal eyes 
(233.0 ± 67.0 m) (P < 0.001). In unilateral cases, mean whole macular choroidal 
thickness was greater in eyes with unilateral CSC than in unaffected fellow eyes (P = 
0.021). There was no significant difference in choroidal thickness between active eyes 
and resolved eyes in any of the ETDRS sectors. Mean choroidal thickness was greater 
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thickness was greater in areas with choroidal vascular hyperpermeability and in areas 
with punctate hyperfluorescent spots on IA than in unaffected areas (P < 0.001 for 
both). 
Conclusions: Increased choroidal thickness was observed in the whole macular area 
of eyes with any of the CSC subtypes. Choroidal thickness was related to leakage from 
the retinal pigment epithelium, choroidal vascular hyperpermeability, and punctate 
hyperfluorescent lesions. These findings provide evidence that CSC may be caused by 
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Central serous chorioretinopathy (CSC) is characterized by serous retinal detachment 
(SRD) in the macula, often accompanied by small serous pigment epithelial 
detachments and retinal pigment epithelium (RPE) atrophy. Indocyanine green 
angiography (IA) shows filling delay in choroidal arteries in addition to 
choriocapillaris,(1-6) vascular dilatation,(2,4,5) multiple areas of choroidal vascular 
hyperpermeability,(1-17) and punctuate hyperfluorescent spots.(14) These angiographic 
findings strongly suggest that the principle mechanism underlying CSC involves 
choroidal vascular changes.(1-14) 
Imaging of the choroid with commercially available optical coherence tomography 
(OCT) does not allow visualization of the entire choroidal structure, due to its low 
penetration and high backscattering at the level of the RPE. However, since Spaide and 
associates (15) introduced enhanced depth imaging (EDI) OCT, an increasing number of 
investigators have studied choroidal thickness in healthy and diseased eyes.(16-25) In fact, 
using the EDI-OCT technique, it has been reported that subfoveal choroidal thickness is 
increased in patients with CSC compared with patients with normal eyes.(18,19) However, 
EDI-OCT is usually coupled to multiple averaging to achieve high contrast and low 
speckle noise, resulting in less detailed raster scan images. For this reason, previous 
studies have focused on subfoveal choroidal thickness only. On the other hand, the 
relationship between choroidal thickness and angiographic changes in those eyes 
remains elusive. 
Recently, other investigators reported the measurement of choroidal thickness with the 
use of OCT at a longer wavelength.(26-28) In these more recent studies, higher 
penetration of the OCT probe light, which uses a center wavelength of approximately 
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allows us to visualize the entire choroid without resorting to the EDI system or 
multi-averaging.(26,27) Swept-source (SS)-OCT at a longer wavelength, which is 
characterized by a high-speed scan rate and a relatively low sensitivity roll-off versus 
depth compared with the spectral-domain OCT, allows us to obtain a three-dimensional 
(3D) high-contrast image of the choroid.(29-34) 
In the study described hereafter, we scanned the whole macular area of eyes with CSC 
by high-penetrating SS-OCT, using a 3-D raster scan protocol, and produced a 
choroidal thickness map of the macular area. By applying both the sectors used by the 
Early Treatment Diabetic Retinopathy Study (ETDRS) and square grid sectors to this 
map, we measured the mean choroidal thickness in each area. In addition, we 
investigated the relationship between choroidal thickness and angiographic changes. 
 
METHODS 
All investigations adhered to the tenets of the Declaration of Helsinki, and the study was 
approved by the institutional review board and the ethics committee at Kyoto University 
Graduate School of Medicine. After the nature of and possible consequences of the 
study were explained, written informed consent was obtained from all participating 
subjects. 
Subjects 
This prospective cross-sectional study enrolled 34 patients (31 men and 3 women; 44 
eyes) with CSC but without any other macular abnormality, who visited the Macular 
Service at Kyoto University Hospital, Kyoto, Japan, between October 2010 and March 
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All subjects underwent a comprehensive ophthalmologic examination, including 
measurement of best-corrected visual acuity (BCVA) and intraocular pressure, 
autorefractometry/keratometry, indirect ophthalmoscopy, slit-lamp biomicroscopy with a 
contact lens, color fundus photography, and SS-OCT with a prototype system. All 
patients with CSC also underwent simultaneous fluorescein angiography (FA) and IA 
using a confocal laser scanning ophthalmoscope (HRA2; Heidelberg Engineering, 
Dossenheim, Germany). The diagnosis of CSC was based on results of the fundus 
examination, FA, IA, and OCT and exclusion of neovascular maculopathy (i.e., 
age-related macular degeneration, polypoidal choroidal vasculopathy, pathologic 
myopia, idiopathic choroidal neovascularization, and angioid streaks) and other causes 
of SRD (i.e., intraocular inflammation, posterior segment tumor, and drusen). 
Exclusion criteria included history of intraocular surgery including cataract surgery and 
photodynamic therapy (PDT), except for retinal photocoagulation; evidence of 
glaucoma or high intraocular pressure (22 mm Hg); and poor image due to dense 
cataract or unstable fixation. Subjects with systemic diseases or conditions that might 
affect choroidal thickness were also excluded, such as those with diabetes mellitus or 
malignant hypertension, or those who were pregnant. 
Classification of CSC 
CSC patients were classified into 3 types: classic CSC, chronic CSC, and multifocal 
posterior pigment epitheliopathy (MPPE).(35) Classic CSC was defined as one or only 
few specific points of angiographic leakage from the RPE.(13) Chronic CSC was defined 
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areas of leakage.(13) MPPE was defined as multiple massive leakages from the choroid 
into the subretinal space.(35,36) 
All types of CSC eyes were divided into active and resolved eyes. Active eye was 
defined as serous retinal detachment involving the macula. Resolved eye was defined 
by the absence of serous retinal detachment at the time of measurement. 
Choroidal filling delay was observed in the early phase of IA, and choroidal 
hyperpermeability and punctate hyperflourescent spots were determined in the late 
phase of IA. All these angiographic features and classifications were evaluated by an 
experienced ophthalmologist (SO) who was unaware of the SS-OCT results. 
SS-OCT system and scan protocols 
We used an SS-OCT prototype system (Topcon, Tokyo, Japan) with an axial scan rate 
of 100,000 Hz operated at the 1-m wavelength region.(34) In the current SS-OCT 
system, the light source was a wavelength-sweeping laser with a tuning range of 
approximately 100 nm centered at 1050 nm, yielding 8-m axial resolution in tissue. 
Transverse resolution was set to approximately 20 m. A single OCT image consisting 
of 1000 A lines can be acquired in 10 ms. SS-OCT imaging of the cornea was 
conducted at 1050 nm with approximately 1 mW power, which is well below the safe 
retinal exposure limit established by the American National Standards Institute. 
Sensitivity was measured to be approximately 98 dB at this input power. 
SS-OCT examinations were performed by trained examiners after pupil dilation. First, 
horizontal and vertical line scans (12 mm) through the fovea were obtained, and ~50 
B-scan images were averaged to reduce speckle noise. Second, a 3D imaging data set 
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(vertical) A-scans per data set (total, 65,536 axial scans/volume) in 0.8 s. Each 3D scan 
covered an area of 6  6 mm centered on the fovea, which was confirmed by an 
internal-fixation and fundus camera integrated in the instrument. To reduce speckle 
noise, each image was denoised by applying the weighted moving average from 3 
consecutive images. (34) Owing to the invisible scanning light and high-speed scanning, 
eye movement during the 3D-scan was minimal. 
Choroidal thickness measurement 
The choroidal thickness was measured as the distance between Bruch’s membrane (or 
the outer border of the RPE-Bruch’s membrane complex) and the chorioscleral border 
(Fig. 1). In each image of the 3D data set, both lines were determined manually by a 
trained ophthalmologist (JP) who was blinded to the diagnosis, classification, or 
angiographic findings. Automated built-in calibration software was used to determine 
the distance between the 2 lines. From all 128 images of each 3D data set, a choroidal 
thickness map of 6  6 mm was created. After the choroidal thickness map was created, 
the ETDRS sectors were applied to it (Fig. 1A). First, the central fovea on each image 
was manually registered, if necessary, to coincide with the central circle on the ETDRS 
segmentation diagram. The mean thickness of each sector was measured in 4 “inner 
ring” sectors (superior, inferior, nasal, and temporal) 1–3 mm from the center of the 
fovea, and in 4 “outer ring” sectors (superior, inferior, temporal, and nasal) 3–6 mm from 
the center of the fovea. A 5  5 grid sector of 5  5 mm was further applied to the 
thickness map. The 5  5 mm grid divided the macular region into 25 square areas (Fig. 
1B). This grid sector was used for comparison with the angiographic findings. Sectors 
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hyperpermeability were defined as those that involved angiographic abnormalities in 
more than 50% of the area. 
Statistical analyses 
A t-test was used for comparison of variables associated with mean choroidal thickness 
between normal eyes and eyes with CSC, eyes with unilateral CSC and unaffected 
fellow eyes, unaffected fellow eyes with and without choroidal hyperpermeability, active 
eyes and resolved eyes, and areas with angiographic changes and areas without them. 
A t-test was also used for a comparison of age and refractive error between normal 
eyes and CSC eyes, and active eyes and resolved eyes. The Tukey–Kramer test was 
used for comparison of age and refractive error, and for comparison of mean choroidal 
thickness between CSC subtypes. We calculated the Pearson’s correlation coefficient 
and partial correlation to examine associations between choroidal thickness and age or 
refractive error. All statistical evaluations were performed using commercially available 
software programs (SPSS2; SPSS Japan, Tokyo, Japan) (StatMateIII; ATMS, Tokyo, 
Japan). A P value of less than 0.05 was considered to indicate statistical significance. 
 
RESULTS 
In the present study, 44 eyes of 34 patients and 17 eyes of 17 healthy volunteers were 
examined. The mean age was 57.3 ± 13.7 years in eyes with CSC, and 62.1 ± 15.4 
years in normal eyes (P = 0.242, by the t-test). The mean refractive error was 0.8 ± 2.5 
diopters in eyes with CSC, and 0.1 ± 2.5 diopters in normal eyes (P = 0.245, by the 
t-test). Among patients with CSC, 19 (56%) had unilateral evidence or history of serous 
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and 4 had MPPE. Twenty-seven (61%) eyes were classified as active, and 17 (39%) as 
resolved. The mean age and refractive error for each subtype is summarized in Table 1. 
Angiographic data 
All patients with CSC were examined using simultaneous FA and IA. FA showed 
leakage from the RPE in 25 of 27 (93%) active eyes. Early-phase IA was studied in 1 
eye of each patient, and the area with filling delay in choroidal arteries and 
choriocapillaris was seen in 20 of 28 eyes (71%). In late-phase IA, choroidal vascular 
hyperpermeability was seen in all 44 eyes (100%), and punctuate hyperfluorescent 
spots were seen in 40 of 44 eyes (91%). In active eyes, choroidal filling delay was 
observed in 13 of 18 eyes (72%), choroidal hyperpermeability in all 27 eyes (100%), and 
punctuate hyperfluorescent spots in 25 of 27 eyes (93%). In resolved eyes, choroidal 
filling delay was observed in 7 of 10 eyes (70%), choroidal hyperpermeability in all 17 
eyes (100%), and punctuate hyperfluorescent spots in 15 of 17 eyes (88%). 
Macular choroidal thickness in ETDRS sectors 
The mean choroidal thickness of each ETDRS sector was significantly greater in eyes 
with CSC compared with normal eyes (Figs 1 and 2, Table 2). Whole macular choroidal 
thickness in eyes with CSC was 329.3 ± 83.0 m, which was greater than that in normal 
eyes (233.0 ± 67.0 µm) (P < 0.001, by t-test).  
In unilateral cases (n = 19), macular choroidal thickness was greater in 8 of 9 sectors in 
affected eyes than in unaffected fellow eyes (Table 3). The whole macular choroidal 
thickness was greater in eyes with unilateral CSC (326.6 ± 98.4 m) than in unaffected 
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The whole macular choroidal thickness did not differ between unaffected fellow eyes (n 
= 19; 254.2 ± 86.8 m) and the normal eyes (233.0 ± 67.0 m) (P = 0.423, by t-test). 
The whole macular choroidal thickness of the unaffected fellow eyes with choroidal 
hyperpermeability (n = 11; 273.4 ± 86.6 m) was slightly increased compared with eyes 
without choroidal hyperpermeability (n = 8; 227.6 ± 85.3 m) or normal eyes (n = 17; 
233.0 ± 67.0 m), but the difference was not significant (P = 0.268 and P = 0.176, 
respectively, by t-test). 
There was no significant difference between choroidal thickness in active eyes and that 
for resolved eyes in each ETDRS sector (Supplemental Table 1). The mean whole 
macular choroidal thickness was 342.2 ± 75.9 m in active eyes, and 308.8 ± 91.7 m in 
resolved eyes (P = 0.196 by t-test). 
The mean whole macular choroidal thickness was rather more in eyes (n = 7) that had 
undergone laser photocoagulation than in eyes (n = 37) that had not (395.0 ± 74.1 µm 
and 316.8 ± 79.4 µm, respectively; P = 0.020, by t-test) 
Mean choroidal thickness of each area in the ETDRS showed no significant difference 
among classic CSC, chronic CSC, and MPPE; however, all of them showed increased 
thickness compared with normal eyes (Figs. 1 and 2, Table 4). The mean whole 
macular choroidal thickness was 326.9 ± 83.1 m in cases of classic CSC, 325.4 ± 93.3 
m in chronic CSC, and 359.0 ± 15.5 m in MPPE, which were greater than that of 
normal eyes (P < 0.001, P=0.002, P=0.002, respectively, by t-test). 
In active eyes, the mean choroidal thickness of each ETDRS sector showed no 
significant difference between classic CSC, chronic CSC, and MPPE. The mean whole 
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chronic CSC, and 352.0 ± 8.0 m in MPPE. In resolved eyes, the mean choroidal 
thickness of each ETDRS sector showed no significant difference between classic CSC 
and chronic CSC. The mean whole macular choroidal thickness was 292.7 ± 100.1 m 
for classic CSC and 313.4 ± 91.2 m for chronic CSC. 
A significant difference was found in the refractive error between eyes with classic CSC, 
chronic CSC, and MPPE. Therefore, we only analyzed CSC eyes with a refractive error 
of ±1.5 diopters. The mean choroidal thickness of each ETDRS sector showed no 
significant differences between the 3 disease subtypes (Supplemental Table 2). 
Choroidal thickness and angiographic changes 
The relationship between the mean choroidal thickness in each 5  5 grid sector and the 
angiographic findings were evaluated (Fig. 3 and 4; Table 5). Sectors with angiographic 
abnormalities such as choroidal filling delay and hyperpermeability were defined as 
those that involved more than 50% of the sector area. Choroidal thickness was greater 
in areas with leakage on FA (361.9 ± 81.5 m) than in areas without leakage (337.6 ± 
81.5 m) (P = 0.001, by t-test). Choroidal thickness was greater in areas with choroidal 
vascular hyperpermeability on IA (356.8 ± 92.7 m) than in unaffected areas (319.4 ± 
90.7 m) (P < 0.001, by t-test). In addition, choroidal thickness was greater in areas with 
punctate hyperfluorescent spots on IA (367.6 ± 87.9 m) than in unaffected areas 
(333.8 ± 87.9 m) (P < 0.001, by t-test). However, choroidal thickness did not differ 
between areas with choroidal filling delay and areas without it (P = 0.872, by t-test). 
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Supplemental Table 3 shows Pearson’s correlation coefficient and partial correlation 
coefficient between macular choroidal thickness and age or refractive error. The whole 
macular choroidal thickness was correlated significantly with age after adjusting for 
refractive error (r = 0.477; P = 0.001), and with refractive error after adjusting for age (r 
= 0.366; P = 0.016). 
 
Discussion 
Although the pathophysiology of CSC remains unknown, there is strong angiographic 
evidence that the key underlying mechanism involves choroidal vascular abnormalities. 
Studies using IA have shown a variety of choroidal abnormalities in CSC patients, 
including variable filling delay in the regions within the choroid,(2-6) choroidal venous 
dilation,(2,4-5) multiple areas of choroidal vascular hyperpermeability,(1-17) and punctate 
choroidal hyperfluorescent spots,(14) suggesting that a generalized choroidal vascular 
disturbance occurs in CSC. Other studies have shown evidence of hyperdynamic 
circulation within the choroid in eyes with CSC.(37,38) 
Recently, Imamura et al. reported that EDI-OCT demonstrated the presence of a very 
thick choroid in patients with CSC.(18) On the other hand, Maruko et al. reported using 
EDI-OCT that focal laser photocoagulation did not result in any change in choroidal 
thickness, whereas PDT led to choroidal thinning and decreased hyperpermeability 
seen during IA in eyes with CSC.(19) However, in the studies using EDI-OCT, choroidal 
thickness measurements were indicated by a representative value obtained at the 
foveal center. This measurement tends to be influenced by focal thickening or thinning 
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current study, using 3D-raster scanning images obtained by high-penetrating SS-OCT, 
eyes with CSC were found to have thickened choroids in the whole macular area and 
focally increased choroidal thickness associated with angiographic findings. 
Several investigators have reported that foveal choroidal thickness is correlated with 
age, axial length, or refractive error in normal subjects.(16,34,39) We also found that the 
mean macular choroidal thickness had a negative correlation with age and refractive 
error in eyes with CSC. These results suggest that both age and refractive error should 
be considered in measuring choroidal thickness even in pathologic eyes. In the current 
study, age and refractive error-matched normal controls were used, and explorative 
analysis was also performed when no difference was found in age or refractive error in 
eyes with CSC subtypes. 
Central macular choroidal thickness in eyes with CSC was greater than that in normal 
eyes, which is consistent with the results of Imamura et al. (18) and Maruko et al. (20) In 
addition, choroidal thickness in the whole macular area and in each ETDRS-sector area 
was found to be increased in eyes with CSC. This result corresponds to the finding that 
choroidal abnormalities on IA are not only confined to the fovea, but also extend into 
other areas of the macula. Moreover, the central choroidal thickness in unilateral 
symptomatic eyes was greater than the unaffected fellow eyes in most of ETDRS 
sectors. Maruko et al. (20) reported that the subfoveal choroidal thickness in unilateral 
symptomatic eyes was greater than that in fellow eyes, which is consistent with our 
study. They also showed that subfoveal choroidal thickness was greater in unaffected 
fellow eyes than in age-matched normal eyes, and greater in unaffected eyes with 
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hyperpermeabilty. Our subjects showed a similar tendency, but the results were not 
statistically significant, probably because of the small sample size. 
There was no significant difference in the choroidal thickness between active eyes and 
resolved eyes. These findings suggest that choroidal thickness is increased in patients 
with CSC regardless of the resolution of serous retinal detachment. In addition, Iida et 
al.(5) found that choroidal vascular abnormalities in IA persist in both eyes even after the 
cessation of leakage from the RPE. Thus, choroidal structural abnormalities may persist 
even after the resolution of serous retinal detachment. These findings may have a 
relationship with the well-known phenomenon that serous retinal detachment tends to 
recur, especially in areas with choroidal hyperpermeability, in patients with CSC. (5, 10-11) 
Maruko et al reported that, in a longitudinal study, focal laser photocoagulation did not 
result in any change in choroidal thickness although serous retinal detachment was 
decreased.(19) In the current cross-sectional study, the mean choroidal thickness of eyes 
with a history of laser photocoagulation was rather greater than that of eyes without 
photocoagulation treatment. Taken together, it seems that laser photocoagulation 
therapy does not result in a decrease in choroidal thickness, but just covers the leakage 
from RPE. 
Some patients with CSC have shown recent onset of the disease with 1 or only a few 
specific points of leakage from the RPE; these eyes are commonly termed as having 
classic CSC.(19) Other patients with chronic disease have broad areas of granular 
hyperfluorescence during FA, associated with many indistinct areas of leakage. These 
patients have chronic CSC, which has also been called diffuse retinal pigment 
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serous retinal detachment in the posterior pole and bullous retinal detachment in the 
lower periphery, was reported as bullous retinal detachment in 1973,(36) and termed as 
MPPE in 1999.(35) MPPE has been considered as an unusual manifestation and severe 
form of CSC.(35) In the current study, all eyes of these types showed choroidal 
hyperpermeability, and choroidal thickness was equally increased in classic CSC, 
chronic CSC, and MPPE. The underlying IA abnormality unifying them is choroidal 
vascular hyperpermeability, and the underlying OCT finding unifying them is increased 
choroidal thickness. Thus, classic CSC, chronic CSC, and MPPE may share a common 
pathology with choroidal vascular abnormalities, although the visual prognosis is 
different. 
Choroidal thickness was greater in the area with leakage points on FA than in the area 
without it. Moreover, choroidal thickness was greater in the area with choroidal 
hyperpermeability on IA than in the unaffected areas. Increase in hydrostatic pressure 
within the choroid sufficient to cause changes to the overlying RPE and retina may 
cause structural changes within the choroid itself. Focal thickening of the choroid in 
these areas may suggest that focal hydrostatic pressure within the choroid is increased 
in the area with choroidal vascular hyperpermeability, resulting in pigment epithelial 
detachment with subsequent RPE defect,(40) which in turn results in focal leakage into 
the subretinal space. In addition, choroidal thickness was greater in areas with punctate 
hyperfluorescent spots on IA than in unaffected areas. Punctate hyperfluorescent spots 
have been reported to be located in the inner choroid, and seen at the center of the 
focal hyperfluorescent area on IA. This area often expands from the punctate spots,(14) 
possibly resulting in increased pressure in the inner choroid and/or Bruch’s membrane 
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in the area with punctate lesions may be explained by increased pressure in the inner 
choroid. 
There are some limitations to this study. Although the high-penetrating SS-OCT 
increases the sensitivity of the choroid, scattering of light by the RPE and choroid still 
occurs, which makes visualization of the chorio–scleral interface difficult in some 
patients. There is currently no automated segmentation software available for 
measuring choroidal thickness, thus we performed all segmentations manually. 
However, we have previously shown good interobserver repeatability with this 
technique.(34) Despite these limitations, we demonstrated that choroidal thickness was 
increased in the whole macular area in all types of CSC, and that choroidal thickness 
was associated with leakage from the RPE, choroidal vascular hyperpermeability, and 
punctate hyperfluorescent lesions. These findings provide additional evidence that CSC 
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Table 1. Mean age and refractive error in eyes with each CSC subtype 
 
 
CSC eyes P* P
† P‡ P§ 
Subtype Status     
Classic 
(n = 23) 
Chronic 
(n = 17) 
MPPE 
(n = 4) 
Active 
(n = 27) 
Resolved 
(n = 17) 
    
Patient age 
(years) 
53.3 ± 11.5 63.0 ± 14.1 56.5 ± 19.1 58.5 ± 14.3 55.5 ± 14.3 0.067 0.894 0.653 0.485 
Refractive error 
(diopters) 
1.8 ± 2.8 0.0 ± 1.8 1.5 ± 0.7 1.1 ± 3.0 0.4 ± 1.7 0.045 0.035 0.525 0.397 
Values are represented as mean ± standard deviation. 
CSC, central serous chorioretinopathy; MPPE, multifocal posterior pigment epitheliopathy 
* Comparison between classic CSC and chronic CSC by the Turkey–Kramer test 
† Comparison between classic CSC and MPPE by the Turkey–Kramer test 
‡ Comparison between chronic CSC and MPPE by the Turkey–Kramer test 






































Table 2. Mean choroidal thickness in eyes with CSC and in normal eyes 
Area (m) 
CSC  
(n = 44) 
Normal eyes 
(n = 17) 
P* 
Whole macula 329.3 ± 83.0 233.0 ± 67.0 <0.001 
Center 374.3 ± 92.9 248.4 ± 77.4 <0.001 
Inner temporal 366.5 ± 91.5 247.4 ± 76.8 <0.001 
Inner superior 363.2 ± 92.9 250.4 ± 73.4 <0.001 
Inner nasal 352.7 ± 96.1 229.6 ± 77.6 <0.001 
Inner inferior 360.1 ± 93.4 246.3 ± 72.7 <0.001 
Outer temporal 327.2 ± 83.0 237.6 ± 72.3 <0.001 
Outer superior 333.5 ± 88.0 261.9 ± 67.2 0.004 
Outer nasal 285.7 ± 91.3 189.0 ± 70.3 <0.001 
Outer inferior 326.9 ± 82.7 228.8 ± 68.6 <0.001 
Values are represented as mean ± standard deviation.  
CSC, central serous chorioretinopathy 














































































(n = 19) 
Unaffected 
fellow eyes 
(n = 19) 
P* 
Whole macula 326.6 ± 98.4 254.2 ± 86.8 0.021 
Center 376.5 ± 115.2 287.6 ± 101.6 0.016 
Inner temporal 373.0 ± 116.8 286.0 ± 98.3 0.018 
Inner superior 353.7 ± 110.7 275.8 ± 89.4 0.022 
Inner nasal 348.3 ± 112.8 260.4 ± 98.0 0.015 
Inner inferior 368.5 ± 112.2 269.0 ± 100.8 0.007 
Outer temporal 330.5 ± 104.6 263.2 ± 86.7 0.038 
Outer superior 322.3 ± 96.8 265.1 ± 84.5 0.060 





































Outer inferior 330.1 ± 92.9 254.4 ± 86.8 0.014 
Values are represented as mean ± standard deviation.  
CSC, central serous chorioretinopathy 
Inner, 1–3 mm from the foveal center; Outer, 3–6 mm from the central fovea 






































Table 4 Mean choroidal thickness in each subtype of central serous chorioretinopathy vs normal eyes 




P-value‡   
(t-test) Classic (n=23) Chronic (n=17) MPPE (n=4) 
Whole macula 326.9±83.1 325.4±93.3 359.0±15.5 233.0±67.0 <0.001 0.002 0.002 
Center 374.2±94.9 368.7±103.0 398.7±17.1 248.4±77.4 <0.001 0.001 0.001 
Inner temporal 365.0±94.8 368.2±100.4 367.9±17.6 247.4±76.8 <0.001 <0.001 0.006 
Inner superior 360.5±96.0 362.2±101.9 382.6±16.9 250.4±73.4 <0.001 0.001 0.002 
Inner nasal 346.7±94.0 350.3±110.0 396.9±15.9 229.6±77.6 <0.001 0.001 <0.001 
Inner inferior 354.1±90.7 361.6±108.8 387.7±17.3 246.3±72.7 <0.001 0.001 0.001 
Outer temporal 327.1±86.6 326.5±90.3 331.2±16.9 237.6±72.3 0.001 0.003 0.021 
Outer superior 338.9±89.3 317.7±95.6 369.6±17.5 261.9±67.2 0.005 0.058 0.006 
Outer nasal 277.2±89.7 283.2±101.3 344.9±23.6 189.0±70.3 0.002 0.004 <0.001 
Outer inferior 322.±80.8 326.3±95.0 355.2±25.9 228.8±68.6 <0.001 0.002 0.002 
Values are mean ± standard deviation 





































Inner = 1-3 mm from foveal center; Outer = 3-6 mm from central fovea. 
* Comparison between classic CSC and normal eyes by t-test  
† Comparison between chronic CSC and normal eyes by t-test 





































Table 5. Mean choroidal thickness in areas with angiographic abnormalities versus 
areas without angiographic abnormalities 
Area (m) Affected area Unaffected area  P* 
FA leakage 361.9 ± 81.5 337.6 ± 81.5 0.001 
Choroidal filling delay 339.1 ± 100.3 340.6 ± 93.9 0.872 
Choroidal 
hyperpermeability 




367.6 ± 87.9 333.8 ± 87.9 <0.001 
Values are represented as mean ± standard deviation. 
FA, fluorescence angiography 





































Supplemental Table 1. Mean choroidal thickness in active and resolved eyes 
Area (m) 
Active eyes 
(n = 27) 
Resolved eyes 
(n = 17) 
P* 
Whole macula 342.2 ± 75.9 308.8 ± 91.7 0.197 
Center 386.8 ± 89.9 354.4 ± 96.9 0.265 
Inner temporal 375.9 ± 86.2 351.5 ± 100.2 0.395 
Inner superior 371.9 ± 92.1 349.2 ± 95.4 0.437 
Inner nasal 370.0 ± 93.2 325.1 ± 97.0 0.133 
Inner inferior 375.0 ± 85.1 336.3 ± 103.5 0.184 
Outer temporal 334.2 ± 74.4 316.3 ± 96.5 0.493 
Outer superior 344.5 ± 84.2 316.0 ± 93.5 0.300 
Outer nasal 302.7 ± 84.2 258.6 ± 98.2 0.120 
Outer inferior 343.9 ± 66.4 299.8 ± 99.7 0.085 
Values are represented as mean ± standard deviation.  
CSC, central serous chorioretinopathy 
Inner, 1–3 mm from the foveal center; Outer, 3–6 mm from the central fovea 





































Supplemental Table 2. Mean choroidal thickness in eyes of each CSC subtype with 
refractive error of ±1.5 diopters 




(n = 15) 
Chronic 
(n = 10) 
MPPE 
(n = 2) 
Whole macular 352.2 ± 85.1 342.5 ± 107.3 361.5 ± 26.4 0.964 0.990 0.962 
Center 405.7 ± 92.6 379.7 ± 115.2 392.6 ± 23.2 0.802 0.983 0.985 
Inner temporal 393.5 ± 97.9 374.1 ± 119.6 363.3 ± 25.3 0.893 0.922 0.990 
Inner superior 389.0 ± 99.1 378.4 ± 125.7 384.9 ± 18.5 0.969 0.999 0.997 
Inner nasal 377.9 ± 92.8 364.9 ± 120.7 392.3 ± 25.4 0.949 0.981 0.937 
Inner inferior 384.9 ± 88.3 377.5 ± 125.2 376.6 ± 19.1 0.982 0.993 1.000 
Outer temporal 350.4 ± 92.0 337.6 ± 110.9 333.5 ± 26.1 0.945 0.971 0.998 
Outer superior 366.1 ± 93.0 341.3 ± 112.7 370.6 ± 23.6 0.814 0.998 0.923 
Outer nasal 303.1 ± 94.9 341.3 ± 112.7 370.6 ± 23.6 0.976 0.812 0.760 
Outer inferior 341.0 ± 81.9 354.1 ± 98.2 366.9 ± 25.2 0.928 0.918 0.981 
Values are represented as mean ± standard deviation.  
CSC, central serous chorioretinopathy; D, diopter; MPPE, multifocal posterior 
pigment epitheliopathy 
Inner, 1–3 mm from the foveal center; Outer, 3–6 mm from the central fovea 
* Comparison between classic CSC and chronic CSC by the Turkey–Kramer test 










































































Supplemental Table 3. Pearson’s correlation and partial correlation coefficient between choroidal thickness and age/refractive error 




P R (Partial 
correlation 
coefficient) 
P R (Pearson’s 
correlation 
coefficient) 




Whole macular 0.401 0.007 0.477 0.001 0.244 0.111 0.366 0.016 
Center 0.373 0.013 0.461 0.002 0.281 0.064 0.396 0.009 
Inner temporal 0.383 0.010 0.447 0.003 0.211 0.169 0.323 0.035 
Inner superior 0.463 0.003 0.482 0.001 0.146 0.345 0.269 0.081 
Inner nasal 0.318 0.035 0.417 0.005 0.325 0.031 0.423 0.005 
Inner inferior 0.285 0.061 0.390 0.010 0.346 0.022 0.433 0.004 
Outer temporal 0.456 0.002 0.508 0.001 0.164 0.289 0.298 0.053 





































Outer nasal 0.258 0.091 0.354 0.020 0.330 0.029 0.406 0.007 







































































































































































































































































Figure 1. A choroidal thickness map obtained by high-penetrating swept source-optical 
coherence tomography in a normal eye. (A) Three-dimensional raster scan covered a 6 × 6 mm 
area centered on the fovea. The Early Treatment Diabetic Retinopathy Study sector was applied 
to the scanned area and the mean choroidal thickness of 9 sectors was measured. (B) The 5 × 5 
mm squared grid sector was applied to the scanned area, and the mean choroidal thickness of 
25 square areas was measured. (C) B-scan images at difference levels of the raster scan. Green 
lines indicate the segmentation lines that show Bruch’s membrane (outer side of the retinal 









































Figure 2. Macular choroidal thickness in each subtype of central serous chorioretinopathy 
(CSC). (A) Active classic CSC. (Top, left) Fluorescein angiography (FA) shows an ink blot 
pattern of leakage; (Top, middle) Indocyanine green angiography (IA) shows choroidal 
hyperpermeability and punctate hyperfluorescent spots; (Top, right) Choroidal thickness map 
shows increased choroidal thickness in the whole macula. (2nd row, bottom) SS-OCT images 
(12 mm) of the fovea show serous retinal detachment and a thick choroid. (B) Active chronic 
CSC. (Top, left) FA shows broad areas of granular hyperfluorescence during FA associated 
with many indistinct areas of leakage; (Top, middle) IA shows choroidal hyperpermeability 
and punctuate hyperfluorescent spots; (Top, right) Choroidal thickness map shows increased 
choroidal thickness in the whole macula. (2nd row, bottom) SS-OCT images (12 mm) through 
the fovea show serous retinal detachment involving the fovea, thin central retina, and thick 
choroid. (C) Active multifocal posterior pigment epitheliopathy. (Top, left) FA shows multiple 
massive leakages from the RPE; (Top, middle) IA shows several areas of choroidal 
hyperpermeability and punctuate hyperfluorescent spots; (Top, right) Choroidal thickness 
map shows increased choroidal thickness in the whole macula. (2nd row, bottom) SS-OCT 
images (12 mm) through the fovea show serous retinal detachment and a thick choroid. (D) 
Resolved classic CSC. (Top, left) FA shows a window defect and no remarkable leakage; 
(Top, middle) IA shows several areas of choroidal hyperpermeability and punctuate 
hyperfluorescent spots; (Top, right) Choroidal thickness map shows increased choroidal 
thickness in the whole macula. (2nd row, Bottom) SS-OCT images (12 mm) through the fovea 







































 Figure 3. Comparison of the mean choroidal thickness and angiographic findings in an eye 
with active chronic central serous chorioretinopathy. (A) Fluorescein angiography (FA) shows 
diffuse leakage (red triangle). (B) Late-phase indocyanine angiography (IA) shows choroidal 
hyperpermeability (red arrowheads) and punctate hyperfluorescent spots (blue stars). (C) 
SS-OCT images (12 mm) show serous retinal detachment in the fovea and a thick choroid. 
(D) The mean choroidal thickness in areas with FA leakage indicted by red (442.5 m) was 
greater, compared with non-FA leakage areas (397.1 m). (F) The mean choroidal thickness 
in areas with choroidal hyperpermeability indicated by red (458.7 m) was greater, compared 
with the non-hyperpermeability areas (387.2 m). (G) The mean choroidal thickness in areas 
with punctuate hyperfluorescent spots indicated by red (434.7 m) was greater, compared 








































Figure 4. Comparison of the mean choroidal thickness and angiographic findings in an eye 
with resolved chronic central serous chorioretinopathy. (A) Fluorescein angiography (FA) 
shows a window defect in an area with retinal pigment epithelium alteration, and no 
remarkable leakage. (B) Early phase indocyanine angiography (IA) shows filling delay in 
choroidal arteries and choriocapillaris (red arrows). (C) Late-phase IA shows choroidal 
hyperpermeability (red arrowheads) and punctate hyperfluorescent spots (blue stars). (D) 
SS-OCT images (12 mm) show no serous retinal detachment, but show a thick choroid. (E) 
The mean choroidal thickness in areas with filling delay indicated by red (247.1 m) was 
almost equal to that in non-filling delayed areas (243.5 m). (F) The mean choroidal 
thickness in areas with choroidal hyperpermeability indicated by red (302.7 m) was greater 
than that in non-hyperpermeability areas (223.4 µm). (G) The mean choroidal thickness in 
areas with punctuate hyperfluorescent spots indicated by red (303.5 µm) was greater than 
that in non-punctate hyperfluorescent areas (240.6 m). 
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